biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes
← People to follow
Rudolph Tanzi
Photo: Neurogenie, CC BY-SA 4.0, via Wikimedia Commons
PERSON TO FOLLOW

Rudolph Tanzi

Director, McCance Center for Brain Health, Mass General Brigham

A neuroscientist at Massachusetts General Hospital since 1980 who helped discover three genes behind rare early-onset forms of Alzheimer's disease. His team created the 'Alzheimer's in a Dish' lab model in 2014, and he cofounded the Boston biotech Acta Pharmaceuticals.

alzheimer's diseasedementia preventiongeneticsdrug repurposing

WHAT TO WATCHWhether the federally funded prevention trial and Acta's early drug trial report blood-test or safety results.

ON THE WIRE

Every story about Rudolph’s work.

Profile sources

  1. 1
    ARPA-H funding will launch accelerated drug-testing platform for Alzheimer’s disease at Mass General Brigham | Mass General Brigham news.massgeneralbrigham.org
  2. 2
    ‘Everything’s coming to fruition’: Renowned MGB neuroscientist to receive millions to combat Alzheimer’s - The Boston Globe BostonGlobe.com